SCHV vs VHT
Schwab US Large-Cap Value ETF vs Vanguard Health Care ETF
- • SCHV has the lower expense ratio at 0.04% vs 0.09% for VHT.
- • SCHV pays a higher dividend yield (1.81%).
Side-by-side metrics
| Metric | SCHV | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.81% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $15.68B | $23.73B |
YTD return | 18.70% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.73 | 0.46 |
P/E ratio | 20.43 | 32.41 |
Last price | $34.95 | $347.68 |
Inception | — | — |
Issuer | Schwab | Vanguard |
SCHV top holdings
| BRK-B | Berkshire Hathaway Inc Class B | 3.32% |
| JPM | JPMorgan Chase & Co | 2.95% |
| XOM | ExxonMobil Holdings Corp | 2.53% |
| JNJ | Johnson & Johnson | 2.16% |
| WMT | Walmart Inc | 1.81% |
| ABBV | AbbVie Inc | 1.71% |
| CVX | Chevron Corp | 1.53% |
| CSCO | Cisco Systems Inc | 1.35% |
| PG | Procter & Gamble Co | 1.23% |
| MRK | Merck & Co Inc | 1.21% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost. Managed by Schwab, the fund carries $15.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.81%. Its largest holding is Berkshire Hathaway Inc Class B (BRK-B), which represents 3.3% of the portfolio. Real Estate is the fund's largest sector exposure at 4.0%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.